Indenture Agreements in the Pharmaceuticals Industry

561 Contracts & Agreements

Browse by Company

Acreage Holdings, Inc. (3 contracts)
Aegerion Pharmaceuticals, Inc. (2)
AERIE PHARMACEUTICALS INC (2)
Akorn (1)
ALDER BIOPHARMACEUTICALS INC (3)
Alexza Pharmaceuticals Inc. (2)
Allergan, plc (14)
Amag Pharmaceuticals (6)
Amneal Pharmaceuticals, Inc. (6)
Amphastar Pharma (1)
AMYLIN PHARMACEUTICALS INC (4)
Anacor Pharmaceuticals, Inc. (3)
ANGIOTECH PHARMACEUTICALS INC (1)
ANI Pharma Inc (5)
Aquestive Therapeutics, Inc. (6)
ARADIGM CORP (2)
Aralez Pharmaceuticals Inc. (3)
ARIAD PHARMACEUTICALS INC (1)
Assertio Holdings, Inc. (3)
Assertio Therapeutics, Inc (4)
AUXILIUM PHARMACEUTICALS INC (4)
AVADEL PHARMACEUTICALS PLC (4)
Bausch Health Companies Inc. (94)
Blue Water Acquisition Corp. (2)
BRADLEY PHARMACEUTICALS INC (2)
Bristol-Myers Squibb (10)
Canopy Growth Corp (3)
Catalent Inc (6)
CELGENE CORP (15)
CLS Holdings USA, Inc. (10)
COLLEGIUM PHARMACEUTICAL, INC (3)
Columbia Care Inc. (3)
CUBIST PHARMACEUTICALS INC (4)
Egalet Corp (2)
Elanco Animal Health Inc (2)
ENCYSIVE PHARMACEUTICALS INC (2)
Endo International plc (73)
Endo Pharmaceuticals Solutions Inc. (3)
EPIX Pharmaceuticals, Inc. (1)
GUILFORD PHARMACEUTICALS INC (1)
HARROW HEALTH, INC. (3)
HARVEST HEALTH & RECREATION INC. (2)
Horizon Pharma plc (18)
IDENIX PHARMACEUTICALS INC (1)
Innoviva, Inc. (6)
IntelGenx Technologies Corp. (6)
Iterum Therapeutics plc (2)
Jazz Pharmaceuticals plc (6)
Johnson & Johnson (1)
Jushi Holdings Inc. (1)
KEMPHARM, INC (1)
KING PHARMACEUTICALS INC (1)
Lannett Company, Inc. (1)
Lilly (Eli) & Co. (5)
Mallinckrodt (6)
Medicine Man Technologies, Inc. (1)
Merck (5)
MILLENNIUM PHARMACEUTICALS INC (1)
Mind Medicine (MindMed) Inc. (1)
Molecular Insight Pharmaceuticals, Inc. (1)
Mylan N.V. (25)
NEKTAR THERAPEUTICS (5)
NEW RIVER PHARMACEUTICALS INC (1)
NPS PHARMACEUTICALS INC (7)
OMEROS CORP (3)
OSCIENT PHARMACEUTICALS CORP (1)
OSI PHARMACEUTICALS INC (1)
Pacira Pharmaceuticals, Inc. (6)
Paratek Pharmaceuticals, Inc. (2)
Perrigo (9)
Pfizer (18)
Phibro Animal Health Corporation (2)
Prestige Brands Holdings Inc (8)
Revance Therapeutics, Inc. (1)
Royalty Pharma plc (6)
SALIX PHARMACEUTICALS LTD (6)
SAVIENT PHARMACEUTICALS INC (2)
Stem Holdings, Inc. (3)
Sucampo Pharmaceuticals, Inc. (2)
Supernus Pharmaceuticals, Inc. (3)
SYNERGY PHARMACEUTICALS, INC. (1)
TETRALOGIC PHARMACEUTICALS CORP (1)
TEVA PHARMACEUTICAL INDUSTRIES LTD (10)
The Medicines Company (7)
Theravance Biopharma, Inc. (3)
Tilray, Inc. (13)
Trevi Therapeutics, Inc. (1)
Tribute Pharmaceuticals Canada Inc. (1)
Tricida, Inc. (1)
Trulieve Cannabis Corp. (2)
Upjohn Inc (11)
VALEANT PHARMACEUTICALS INTERNATIONAL (1)
VION PHARMACEUTICALS INC (1)
VIVUS INC (3)
XERIS PHARMACEUTICALS INC (2)
Zoetis (5)
ZOGENIX, INC. (2)

Recent Contracts

Supplemental Indenture dated December 27, 2024 to Debenture Indenture dated December 12, 2018, as supplemented on March 31, 2021, supplemented on September 15, 2022, and as... (CLS Holdings USA, Inc., Filed With SEC on December 31, 2024)
Seventh Supplemental Indenture dated as of September 17, 2024, among the Issuer, the Company, the Subsidiary Guarantors and Computershare Trust Company, N.A., as trustee (Perrigo, Filed With SEC on September 17, 2024)
Sixth Supplemental Indenture dated as of September 17, 2024, among the Issuer, the Company, the Subsidiary Guarantors and Computershare Trust Company, N.A., as trustee (Perrigo, Filed With SEC on September 17, 2024)
Indenture, dated as of September 6, 2024 among Jazz Pharmaceuticals Public Limited Company, Jazz Investments I Limited and U.S. Bank Trust Company, National Association (Jazz Pharmaceuticals plc, Filed With SEC on September 6, 2024)
Indenture, dated as of August 13, 2024, between ANI Pharmaceuticals, Inc. and U.S. Bank Trust Company, National Association, as trustee (ANI Pharma Inc, Filed With SEC on August 13, 2024)
Supplemental Indenture No. 1, dated as of May 1, 2024, to the Indenture, dated as of November 14, 2023, by and among the Issuers, the Guarantors, Wilmington Savings Fund Society,... (Mallinckrodt, Filed With SEC on August 6, 2024)
Third Supplemental Indenture, dated as of June 10, 2024, among Royalty Pharma plc, Royalty Pharma Holdings Ltd and Wilmington Trust, National Association, as Trustee (Royalty Pharma plc, Filed With SEC on June 10, 2024)
Indenture, dated as of May 30, 2024, among MSD Netherlands Capital B.V., Merck & Co., Inc. and U.S. Bank Trust National Association, as Trustee (Merck, Filed With SEC on May 30, 2024)
Indenture, dated as of May 14, 2024, by and between the Company and Computershare Trust Company, National Association (Pacira Pharmaceuticals, Inc., Filed With SEC on May 14, 2024)
Sixth Supplemental Indenture dated September 20, 2023 between The Cannabist Company Holdings Inc. and Odyssey Trust Company (Columbia Care Inc., Filed With SEC on May 9, 2024)
Seventh Supplemental Indenture dated March 19, 2024 between The Cannabist Company Holdings Inc. and Odyssey Trust Company (Columbia Care Inc., Filed With SEC on March 20, 2024)
Fifteenth Supplemental Indenture, dated as of February 22, 2024, by and between Bristol-Myers Squibb Company and The Bank of New York Mellon, as Trustee, to the Indenture dated as... (Bristol-Myers Squibb, Filed With SEC on February 22, 2024)
Supplemental Indenture dated December 28, 2028 to Debenture Indenture dated December 12, 2018, as supplemented on March 31, 2021, and as further supplemented on September 15,... (CLS Holdings USA, Inc., Filed With SEC on January 2, 2024)
Fourteenth Supplemental Indenture, dated as of November 13, 2023, by and between Bristol-Myers Squibb Company and The Bank of New York Mellon, as Trustee, to the Indenture dated... (Bristol-Myers Squibb, Filed With SEC on November 13, 2023)
First Supplemental Indenture, dated as of September 21, 2023, by and between the Company and U.S. Bank Trust Company, National Association (f/k/a U.S. Bank National Association),... (Paratek Pharmaceuticals, Inc., Filed With SEC on September 21, 2023)
Indenture, dated September 15, 2023, between Amphastar Pharmaceuticals, Inc. and U.S. Bank Trust Company, National Association, as trustee (Amphastar Pharma, Filed With SEC on September 15, 2023)
Indenture, dated July 14, 2023, between the Canopy Growth Corporation and Odyssey Trust Company, as trustee (Canopy Growth Corp, Filed With SEC on July 14, 2023)
Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and TSX Trust Company (Tilray, Inc., Filed With SEC on June 22, 2023)
Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and TSX Trust Company (Tilray, Inc., Filed With SEC on June 22, 2023)
Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and TSX Trust Company (Tilray, Inc., Filed With SEC on June 22, 2023)
Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and TSX Trust Company (Tilray, Inc., Filed With SEC on June 22, 2023)
Third Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and Computershare Trust Company of Canada (Tilray, Inc., Filed With SEC on June 22, 2023)
Third Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and Computershare Trust Company of Canada (Tilray, Inc., Filed With SEC on June 22, 2023)
Second Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and Computershare Trust Company of Canada (Tilray, Inc., Filed With SEC on June 22, 2023)
First Supplemental Indenture, dated May 31, 2023, between Tilray Brands, Inc. and Computershare Trust Company, N.A (Tilray, Inc., Filed With SEC on May 31, 2023)
Indenture, dated May 31, 2023, between Tilray Brands, Inc. and Computershare Trust Company, N.A (Tilray, Inc., Filed With SEC on May 31, 2023)
First Supplemental Indenture, dated as of May 19, 2023, among Pfizer Investment Enterprises Pte. Ltd., Pfizer Inc. and The Bank of New York Mellon, as trustee (Pfizer, Filed With SEC on May 19, 2023)
Indenture, dated as of May 19, 2023, among Pfizer Investment Enterprises Pte. Ltd., Pfizer Inc. and The Bank of New York Mellon, as trustee (Pfizer, Filed With SEC on May 19, 2023)
Indenture, dated as of April 3, 2023, by and between the Issuer, the Company and The Bank of New York Mellon, as Trustee (AVADEL PHARMACEUTICALS PLC, Filed With SEC on April 5, 2023)
Fourth Supplemental Senior Indenture, dated as of March 9, 2023, among Teva Pharmaceutical Finance Netherlands III B.V., Teva Pharmaceutical Industries Limited and The Bank of New... (TEVA PHARMACEUTICAL INDUSTRIES LTD, Filed With SEC on March 9, 2023)
Fourth Supplemental Senior Indenture, dated as of March 9, 2023, among Teva Pharmaceutical Finance Netherlands II B.V., Teva Pharmaceutical Industries Limited, The Bank of New... (TEVA PHARMACEUTICAL INDUSTRIES LTD, Filed With SEC on March 9, 2023)
Indenture, dated February 21, 2023, between the Canopy Growth Corporation and Computershare Trust Company of Canada, as trustee (Canopy Growth Corp, Filed With SEC on February 21, 2023)
Indenture, dated as of February 10, 2023, between Collegium Pharmaceutical, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (COLLEGIUM PHARMACEUTICAL, INC, Filed With SEC on February 13, 2023)
Second Supplemental Indenture, dated as of December 20, 2022, by and between the Company and U.S. Bank Trust Company, National Association (HARROW HEALTH, INC., Filed With SEC on December 20, 2022)
First Supplemental Indenture, dated as of November 21, 2022, by and between Aerie Pharmaceuticals, Inc. and Wilmington Trust, National Association (AERIE PHARMACEUTICALS INC, Filed With SEC on November 21, 2022)
Sixth Supplemental Indenture, dated November 16, 2022, between the Company and Deutsche Bank Trust Company Americas, as Trustee (Zoetis, Filed With SEC on November 16, 2022)
Sixteenth Supplemental Indenture, dated as of September 14, 2022, by and among Bausch Health Americas, Inc. (BHA) and the Bank of New York Mellon, as trustee, amending that... (Bausch Health Companies Inc., Filed With SEC on November 3, 2022)
Fourteenth Supplemental Indenture, dated as of September 14, 2022, by and among Bausch Health Companies Inc. and the Bank of New York Mellon, as trustee, amending that certain... (Bausch Health Companies Inc., Filed With SEC on November 3, 2022)
Fourteenth Supplemental Indenture, dated as of September 14, 2022, by and among Bausch Health Companies Inc. and the Bank of New York Mellon, as trustee, amending that certain... (Bausch Health Companies Inc., Filed With SEC on November 3, 2022)
Fifteenth Supplemental Indenture, dated as of September 28, 2022, by and among Bausch Health Companies Inc. and the Bank of New York Mellon, as trustee, amending that certain... (Bausch Health Companies Inc., Filed With SEC on November 3, 2022)